Top Stories Monday, January 30, 2017 Incyte has paid $53 million upfront for Calithera Biosciences’ small molecule arginase inhibitor CB-1158. The deal sees Incyte sign up to codevelop an asset it sees complementing PD-1 drugs by reversing an immunosuppressive block that dampens the activity of immuno-oncology therapies. Monday, January 30, 2017 With phase 2 trials now underway, AbbVie says it intends to push its anti-tau antibody for neurodegenerative disorders such as Alzheimer's "as quickly as possible." Monday, January 30, 2017 FibroGen has posted positive phase 3 data on its AstraZeneca-partnered anemia drug. Both trials in the Chinese phase 3 program met their primary endpoints, moving FibroGen closer to filing for approval of a drug that enjoys fast-track status in the country. Monday, January 30, 2017 U.K. biotech Scancell is joining forces with the Addario Lung Cancer Medical Institute and Bonnie J. Addario Lung Cancer Foundation to carry out trials of its candidate vaccine for non-small cell lung cancer. | This week's sponsor is Destination Medical Center. | | | Destination Medical Center (DMC) is a 20-year, $5.6 billion economic development plan set to transform Rochester, MN. DMC and Mayo Clinic are accelerating new advancements in life science research, medical technology, patient care, and education. |
| | | Tiny Ocera Therapeutics tumbled after a phase 2b trial of its ammonia scavenger missed its primary endpoint. Release FDA awarded breakthrough status to uniQure’s hemophilia B gene therapy. Statement Gemphire Therapeutics posted an early look at data from a trial of gemcabene in homozygous familial hypercholesterolemia. Release X4 Pharmaceuticals kicked off a phase 2/3 trial of X4P-001-LD in a subtype of primary immunodeficiency disease. Statement | |
|
Resources Sponsored By: Veeva Learn over a dozen best practices for deploying a global content system. Read Whitepaper. Sponsored By: Veeva Gartner provides insightful research on preparing for IDMP compliance. Read Whitepaper. Sponsored By: Veeva Learn How to Create a Unified RIM Environment for IDMP. Find out. Sponsored By: Veeva The largest survey of TMF owners reveals drivers and trends in improving inspection readiness and shortening trial time. Sponsored By: Salesforce Learn how the healthcare and life science industry is using agile application development to drive innovation and accelerate their business with the Salesforce Platform. Presented by: Patheon Can you avoid a risky trial-and-error approach to find the right path for your poorly soluble molecule by utilizing a CDMO? Download this complimentary Whitepaper to learn more! Immuno-Oncology 360° February 1-3, 2017 | The Roosevelt Hotel, New York Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA PEGS: The Essential Protein Engineering Summit May 1-5, 2017 | Boston, MA CBI’s Abuse Deterrent Formulations Summit March 7-8, 2017 | Alexandria, VA BIO CEO & Investor Conference February 13 – 14, 2017 | The Waldorf Astoria, New York, NY |
